Organs-at-risk dose and normal tissue complication probability with dynamic trajectory radiotherapy (DTRT) for head and neck cancer

Radiother Oncol. 2024 Mar 20;195:110237. doi: 10.1016/j.radonc.2024.110237. Online ahead of print.ABSTRACTWe compared dynamic trajectory radiotherapy (DTRT) to state-of-the-art volumetric modulated arc therapy (VMAT) for 46 head and neck cancer cases. DTRT had lower dose to salivary glands and swallowing structure, resulting in lower predicted xerostomia and dysphagia compared to VMAT. DTRT is deliverable on C-arm linacs with high dosimetric accuracy.PMID:38513960 | DOI:10.1016/j.radonc.2024.110237

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - March 21, 2024 Category: Radiology Authors: Jenny Bertholet Paul-Henry Mackeprang Hannes A Loebner Silvan Mueller Gian Guyer Daniel Frei Werner Volken Olgun Elicin Daniel M Aebersold Michael K Fix Peter Manser Source Type: research